New recovery cocktail aims to get women home faster after keyhole surgery

NCT ID NCT07116564

Recruiting now Symptom relief Sponsor: Aga Khan University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a combination of pain medicines and a recovery protocol (ERAS) can shorten hospital stays after laparoscopic gynecologic surgery. About 98 women will be randomly assigned to receive either the ERAS protocol or standard care. The main goal is to see how many hours they stay in the hospital after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Enhanced Recovery After Surgery (ERAS) protocol including celecoxib, lidocaine, fentanyl, and carbohydrate drinks
What this could lead to: If it works, this could lead to shorter hospital stays and less opioid use after gynecologic laparoscopic surgery.
What could go wrong: This is a small, single-center trial with only 98 participants, so results may not apply broadly. The protocol is complex and may not be easy to implement everywhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ERAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ERAS

Contacts and locations

Locations

Aga Khan University, Karachi, Pakistan
RECRUITING

Karachi, Sindh, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.